Personalized Medicine (sometimes referred to as "Predictive Medicine")
PWC estimates the market at $232 billion and doubling by 2015.
As we move to the new paradigm shift from using traditional epidemiological studies for the effectiveness of a drug application to the "right drug for the right person" we encounter the genetic variability of patients. Ongoing patient monitoring and analysis allows M/A/R/C Rx and sponsors to quantify the potential positive and negative risk factor for population studies. Examples of personalized medicine with high success rates are in oncology.
To request more information, click here.